170 related articles for article (PubMed ID: 38909933)
1. Neuromodulatory Effects of Leukotriene receptor antagonists: A comprehensive review.
Sood R; Anoopkumar-Dukie S; Rudrawar S; Hall S
Eur J Pharmacol; 2024 Jun; ():176755. PubMed ID: 38909933
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamic properties of leukotriene receptor antagonists.
Nicosia S
Monaldi Arch Chest Dis; 1999 Jun; 54(3):242-6. PubMed ID: 10441979
[TBL] [Abstract][Full Text] [Related]
3. Cough, asthma, and cysteinyl-leukotrienes.
Niimi A
Pulm Pharmacol Ther; 2013 Oct; 26(5):514-9. PubMed ID: 23774534
[TBL] [Abstract][Full Text] [Related]
4. Modulation of neuroinflammation by cysteinyl leukotriene 1 and 2 receptors: implications for cerebral ischemia and neurodegenerative diseases.
Wang Y; Yang Y; Zhang S; Li C; Zhang L
Neurobiol Aging; 2020 Mar; 87():1-10. PubMed ID: 31986345
[TBL] [Abstract][Full Text] [Related]
5. A review on leukotrienes and their receptors with reference to asthma.
Singh RK; Tandon R; Dastidar SG; Ray A
J Asthma; 2013 Nov; 50(9):922-31. PubMed ID: 23859232
[TBL] [Abstract][Full Text] [Related]
6. Leukotrienes vs. Montelukast-Activity, Metabolism, and Toxicity Hints for Repurposing.
Marques CF; Marques MM; Justino GC
Pharmaceuticals (Basel); 2022 Aug; 15(9):. PubMed ID: 36145259
[TBL] [Abstract][Full Text] [Related]
7. A novel therapeutic potential of cysteinyl leukotrienes and their receptors modulation in the neurological complications associated with Alzheimer's disease.
Rahman SO; Singh RK; Hussain S; Akhtar M; Najmi AK
Eur J Pharmacol; 2019 Jan; 842():208-220. PubMed ID: 30389631
[TBL] [Abstract][Full Text] [Related]
8. Leukotriene C4 induces bronchoconstriction and airway vascular hyperpermeability via the cysteinyl leukotriene receptor 2 in S-hexyl glutathione-treated guinea pigs.
Yonetomi Y; Sekioka T; Kadode M; Kitamine T; Kamiya A; Matsumura N; Fujita M; Kawabata K
Eur J Pharmacol; 2015 May; 754():98-104. PubMed ID: 25704617
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology of leukotriene receptor antagonists. More than inhibitors of bronchoconstriction.
Hay DW
Chest; 1997 Feb; 111(2 Suppl):35S-45S. PubMed ID: 9042025
[TBL] [Abstract][Full Text] [Related]
10. Effects of ONO-6950, a novel dual cysteinyl leukotriene 1 and 2 receptors antagonist, in a guinea pig model of asthma.
Yonetomi Y; Sekioka T; Kadode M; Kitamine T; Kamiya A; inoue A; Nakao T; Nomura H; Murata M; Nakao S; Nambu F; Fujita M; Nakade S; Kawabata K
Eur J Pharmacol; 2015 Oct; 765():242-8. PubMed ID: 26318198
[TBL] [Abstract][Full Text] [Related]
11. Leukotrienes and airway inflammation.
Okunishi K; Peters-Golden M
Biochim Biophys Acta; 2011 Nov; 1810(11):1096-102. PubMed ID: 21352897
[TBL] [Abstract][Full Text] [Related]
12. The role of leukotrienes in allergic rhinitis.
Peters-Golden M; Henderson WR
Ann Allergy Asthma Immunol; 2005 Jun; 94(6):609-18; quiz 618-20, 669. PubMed ID: 15984591
[TBL] [Abstract][Full Text] [Related]
13. Concentration-dependent noncysteinyl leukotriene type 1 receptor-mediated inhibitory activity of leukotriene receptor antagonists.
Woszczek G; Chen LY; Alsaaty S; Nagineni S; Shelhamer JH
J Immunol; 2010 Feb; 184(4):2219-25. PubMed ID: 20083671
[TBL] [Abstract][Full Text] [Related]
14. Leukotrienes and the mechanism by which the LTRAs block their asthma-related effects.
Spector SL
Postgrad Med; 2000 Sep; 108(4 Suppl):6-11. PubMed ID: 19667529
[TBL] [Abstract][Full Text] [Related]
15. Asthma pharmacotherapy: an update on leukotriene treatments.
Trinh HKT; Lee SH; Cao TBT; Park HS
Expert Rev Respir Med; 2019 Dec; 13(12):1169-1178. PubMed ID: 31544544
[No Abstract] [Full Text] [Related]
16. Cysteinyl Leukotriene Receptor Antagonists Associated With a Decreased Incidence of Cancer: A Retrospective Cohort Study.
Jang HY; Kim IW; Oh JM
Front Oncol; 2022; 12():858855. PubMed ID: 35463337
[TBL] [Abstract][Full Text] [Related]
17. Expression of CysLT2 receptors in asthma lung, and their possible role in bronchoconstriction.
Sekioka T; Kadode M; Fujii M; Kawabata K; Abe T; Horiba M; Kohno S; Nabe T
Allergol Int; 2015 Oct; 64(4):351-8. PubMed ID: 26433531
[TBL] [Abstract][Full Text] [Related]
18. Cysteinyl-leukotriene receptor antagonists: present situation and future opportunities.
Capra V; Ambrosio M; Riccioni G; Rovati GE
Curr Med Chem; 2006; 13(26):3213-26. PubMed ID: 17168708
[TBL] [Abstract][Full Text] [Related]
19. Functional characterisation of receptors for cysteinyl leukotrienes in smooth muscle.
Jonsson EW
Acta Physiol Scand Suppl; 1998 Mar; 641():1-55. PubMed ID: 9597121
[TBL] [Abstract][Full Text] [Related]
20. The use of leukotriene receptor antagonists (LTRAs) as complementary therapy in asthma.
Bjermer L; Diamant Z
Monaldi Arch Chest Dis; 2002 Feb; 57(1):76-83. PubMed ID: 12174707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
